Nepsone is a pioneering brand in dermatology that is revolutionizing the field with its novel approach. As a preclinical-stage pharmaceutical company, Nepsone specializes in developing drugs to effectively treat dermatological conditions that stem from an imbalance in the autonomic nervous system. Nepsone's groundbreaking neuroimmunology theory identifies the root cause of these conditions in the immune system, specifically in the imbalance of neuropeptide activity within the body.

By harnessing the body's natural mechanisms, Nepsone's innovative drugs aim to restore balance and provide much-needed relief from these diseases. With a diverse pipeline, Nepsone's drug discovery platform has the potential to address over 10 indications, including psoriasis, alopecia areata, and eczema. These drugs offer both topical and systemic modalities, catering to different needs and providing a comprehensive range of solutions.

Led by a team of experts in the field, including the COO Bjarki Gudlaugsson and the Head of Clinical Development, Svandis Kristjansdottir, Nepsone is dedicated to advancing dermatological treatments. Contact them at their headquarters in Reykjavik, Iceland, to learn more about their groundbreaking research and potential collaborations